Scarring Alopecia (2026): The Hair Loss That Doesn’t Grow Back — and Why Early Matters

Last updated: June 2026 | Written by RK

Almost every other hair-loss condition on this site shares a reassuring feature: the follicle survives. Androgenetic alopecia shrinks follicles but does not kill them; alopecia areata disables them temporarily; telogen effluvium just pushes them into shedding. All of these can, in principle, recover. Scarring alopecia is the exception that makes the rule matter — here the follicle is destroyed and replaced by scar tissue, and what is lost is lost for good.

That single fact changes everything about how scarring alopecia should be approached. It turns hair loss from a cosmetic question into a time-sensitive medical one, because the inflammation is actively destroying follicles while you decide what to do. This guide explains what scarring alopecia is, how to recognise the warning signs, the main types, and why — unlike for pattern baldness — a scalp biopsy is essential rather than optional. It is the condition the rest of the site keeps flagging as the reason to “see a dermatologist promptly.”

What makes it different: the follicle is destroyed

The hair-loss conditions covered elsewhere on this site are non-scarring — the follicle is affected but preserved, which is why recovery is possible. Scarring (the medical term is cicatricial) alopecias are fundamentally different: an inflammatory process targets and destroys the follicle, and fibrous scar tissue takes its place [1].

The destruction of the bulge stem cells is the irreversible step — once those are gone, the follicle cannot regenerate, regardless of treatment [2]. This is why the entire strategy in scarring alopecia is to stop the inflammation before it reaches more follicles, rather than to regrow hair that is already lost. The contrast with the recoverable conditions is stark, and it is the reason early diagnosis is genuinely consequential here in a way it is not for, say, androgenetic alopecia.

How to recognise it: loss of the follicular openings

The defining visible sign of scarring alopecia is the loss of follicular openings — the tiny pores that hairs grow out of. In non-scarring hair loss, those pores remain even where hair is missing, because the follicle is still there. In scarring alopecia they disappear, leaving smooth, shiny skin that looks like a small scar.

Warning signs that point toward scarring rather than ordinary thinning:

• Smooth, shiny bald patches with no visible pores — the core sign.
• Redness or scaling around the hair roots (perifollicular erythema and scale).
• Pustules, papules, or crusting — especially in the neutrophilic types.
• Scalp symptoms — itching, burning, tenderness, or pain. Pattern baldness is typically symptom-free; an itchy, sore, or burning bald area is a red flag.
• A spreading or band-like pattern — a receding frontal band with eyebrow loss (frontal fibrosing alopecia), or loss spreading outward from the crown (central centrifugal cicatricial alopecia).
• Tufting — several hairs emerging from a single opening, “doll’s-hair,” seen in folliculitis decalvans.

The contrast with the conditions covered elsewhere is useful: pattern hair loss preserves the pores and is symptom-free; alopecia areata leaves smooth patches but the pores remain and hair often regrows; telogen effluvium is diffuse shedding with no scarring. Scarring alopecia is the one where the pores vanish.

The main types

Scarring alopecias are classified by the kind of inflammation driving them — which matters because it determines treatment.

The unifying feature across the types: the follicular openings are gone, leaving smooth scarred skin. What differs is the inflammation behind it — and that is what the biopsy reads.

Two of these deserve a specific note. Frontal fibrosing alopecia is increasingly common and is the reason a receding frontal hairline in a postmenopausal woman is not assumed to be pattern loss — it is covered in the menopausal hair loss guide and flagged in the Ludwig scale article. And CCCA is both the most common scarring alopecia in Black women and one where early recognition is especially valuable, because it spreads silently from the crown and the diagnosis is frequently delayed [3].

Why a biopsy is essential here

For androgenetic alopecia, a scalp biopsy is usually unnecessary — the pattern and trichoscopy are enough. For scarring alopecia, the biopsy is central to the diagnosis, for two reasons:

1. It confirms scarring is actually happening — that follicles are being destroyed and replaced by fibrosis, rather than just thinned. This distinction changes the entire management approach.
2. It identifies the inflammatory pattern — lymphocytic versus neutrophilic, and often the specific condition — which directly determines treatment, because the drugs for, say, lichen planopilaris and folliculitis decalvans are different.

A dermatologist takes a small punch biopsy, usually from an active edge of the affected area (where inflammation is ongoing) rather than from the burnt-out centre. Combined with trichoscopy — which shows the loss of follicular openings and perifollicular changes — the biopsy turns “a bald patch” into a specific, treatable diagnosis. Skipping it risks months of the wrong treatment while follicles continue to be lost.

Treatment: stop the inflammation, save what remains

The goal is consistent across all the types — halt the active inflammation to preserve remaining follicles — but the specific drugs depend on the subtype:

• Lymphocytic (LPP, FFA, DLE) — anti-inflammatory and immunomodulating treatment: topical, intralesional, or oral corticosteroids; hydroxychloroquine; and other immunomodulators. In frontal fibrosing alopecia specifically, 5α-reductase inhibitors are commonly used.
• CCCA — anti-inflammatory treatment (often potent topical or intralesional corticosteroids, plus oral options) alongside gentle hair-care modification.
• Neutrophilic (folliculitis decalvans, dissecting cellulitis) — antibiotics (for their anti-inflammatory as well as antibacterial effect) and other anti-inflammatory measures.

Across all of them, treatment is a managed, monitored process with a dermatologist, and success is measured as stabilisation — the disease going quiet and the hair loss stopping — rather than regrowth. Hair transplantation is occasionally considered, but only after the disease has been completely quiescent for a year or more, and even then it carries higher risk in scarred scalp; controlling the active disease always comes first.

What to do

The bottom line

Scarring alopecia is the one hair-loss diagnosis where waiting genuinely costs you, because the inflammation is destroying follicles that will not come back. The signature is the disappearance of the follicular openings — smooth, shiny skin where pores should be — often with redness, scaling, pustules, or scalp symptoms that ordinary pattern loss does not produce. If that describes your scalp, the right move is a dermatologist promptly and a low threshold for a scalp biopsy, because the diagnosis and the treatment both depend on what the inflammation looks like under the microscope. Caught early, most of the hair can usually be saved; caught late, more is lost permanently. That asymmetry is the whole reason this article exists.

What to read next

• Alopecia Areata vs Androgenetic Alopecia (2026) — the two big non-scarring conditions, and how their smooth patches differ from scarring ones.
• Telogen Effluvium: The Complete Guide (2026) — diffuse, recoverable shedding, the opposite of scarring loss.
• Menopausal Hair Loss (2026) — including frontal fibrosing alopecia, the scarring condition that mimics a receding hairline.
• The Ludwig Scale Explained (2026) — staging female pattern loss, and the moving-hairline red flag that points toward FFA.

References

[1] Olsen EA, Bergfeld WF, Cotsarelis G, et al. “Summary of North American Hair Research Society (NAHRS)-sponsored Workshop on Cicatricial Alopecia, Duke University Medical Center, February 10 and 11, 2001.” J Am Acad Dermatol. 2003;48(1):103-110.

[2] Harries MJ, Paus R. “The pathogenesis of primary cicatricial alopecias.” Am J Pathol. 2010;177(5):2152-2162.

[3] Malki L, Sarig O, Romano MT, et al. “Variant PADI3 in Central Centrifugal Cicatricial Alopecia.” N Engl J Med. 2019;380(9):833-841.

[4] Tan E, Martinka M, Ball N, Shapiro J. “Primary cicatricial alopecias: clinicopathology of 112 cases.” J Am Acad Dermatol. 2004;50(1):25-32.

Disclaimer: This article is educational, not diagnostic, and scarring alopecia is the hair-loss category where that distinction matters most. Distinguishing a scarring from a non-scarring alopecia — and identifying the specific subtype — requires a board-certified dermatologist, trichoscopy, and almost always a scalp biopsy. Because active scarring permanently destroys follicles, any smooth, symptomatic, or spreading area of hair loss deserves prompt professional evaluation rather than watchful waiting.